Systemic administration of STING agonist promotes myeloid cells maturation and antitumor immunity through regulating hematopoietic stem and progenitor cell fateTianxiao Xu(Peking University), Jun Guo(Peking University Cancer Hospital)Cancer Immunology ImmunotherapyAugust 7, 202310.1007/s00262-023-03502-7Cited by 8SaveCiteExport RISWatch citationsRelated PapersMicroRNA-23a-3p Inhibits Mucosal Melanoma Growth and Progression through Targeting Adenylate Cyclase 1 and Attenuating cAMP and MAPK Pathways|Theranostics|2019|70